A Prospective Clinical Study for Safety and Efficacy of Intralesional Tuberculin Purified Protein Derivative in Treatment of Palmoplantar Verruca. (2022). Journal of Nobel Medical College, 11(1), 12-16. https://doi.org/10.3126/jonmc.v11i1.45720